Aug 17, 2026
  • Footballers Millie Bright, Jen Beattie and Bethany England front a new campaign by Novartis UK in partnership with Breast Cancer Now, the UK's leading breast cancer charity, urging women to check for signs of breast cancer and recurrence.
  • Proportion of UK women regularly* checking their breast for signs of cancer dropped from 55% in January 2022 to just 45% in April 20261.
  • Around two thirds of breast cancer cases in England are found through breast-checking and getting unusual changes checked by a GP2.
  • Breast cancer cases are on the rise - by 2040, 70,300 women will be diagnosed with this devastating disease every year in the UK3, making it crucial women make breast checking a habit.

Less than half of women are regularly checking their breasts for signs of cancer, new data reveals. 

The proportion of UK women regularly* checking their breast for signs of cancer – at least once every six weeks – has dropped from 55% in January 2022 to just 45% in April 20261

These new YouGov figures, commissioned by the UK’s leading breast cancer charity Breast Cancer Now, show a decline in breast checking behaviours among women across the UK that the charity warns are a cause for concern. 

Breast Cancer Now cautions that anyone can get breast cancer and that 1 in 7 women in the UK will develop it in their lifetime4.

In England, around two-thirds of breast cancers are found by women breast checking2, and when it's found early, treatment is much more likely to be successful. Checking your breasts can save your life, making it vital that all women make regular breast checking a habit. 

This trend is especially worrying with breast cancer cases in the UK predicted to rise from 55,0005 to around 70,300 every year by 2038-20403.

The most cited barriers to women regularly checking their breasts include simply forgetting, not being in the habit, and feeling uncomfortable doing so.

Backed by women’s football stars, the charity is encouraging everyone to check their breasts regularly, saying it’s as simple as TLC; Touch your breasts, look for changes and check anything new or unusual with a GP.

Manveet Basra, associate director of public health, inclusion and awareness at Breast Cancer Now says:

“Breast checking is a simple habit that can save your life, so it’s deeply concerning that less than half of women in the UK are regularly checking their breasts. 

Around two-thirds of breast cancers are found through women checking their breasts and getting any new or unusual changes checked by a GP2. The sooner breast cancer is diagnosed, the better the chances of treatment being successful, and of lives being saved.

We understand life gets busy, as is reflected in the top reasons women give for not regularly breast checking being that they forget to check or are not in the habit. 

That’s why we’re so thrilled to having the backing of Millie, Jen and Bethany as we partner with Novartis to get our vital message out to women far and wide to check your breasts, it could save your life. 

Breast checking only takes a few minutes and there's no right way to do it, as long as it’s done regularly. It might be while you’re getting dressed, showering or applying moisturiser. It’s important to remember to check the whole breast area, up to your armpits and collarbone (upper chest) for any changes. 

Many women know that a lump can be a possible symptom of breast cancer, but other signs of the disease to look for also include nipple discharge, dimpling or puckering of the skin of the breast, or changes in size or shape of the breast. Changes in the colour of the breast may also appear differently on various skin tones. Most breast changes, including lumps, won’t be cancer, but it’s important to get any new or unusual changes checked by a GP8.”

The research also showed that many women are increasingly deprioritising their health, often as a result of competing pressures in their daily lives.

It revealed that:

  • Rising stress levels, cost of living pressures and shifting lifestyles amongst women mean many healthy habits are falling away - including regular breast checks6.
  • Cost-of-living pressures are also having a significant impact. Nearly half of women (48%) said their health was negatively affected at the peak in April 2024. While this has improved slightly to 44% in September 2025, it remains higher than the 37% reported in 20231,6.

Against this backdrop, Novartis UK is partnering with Breast Cancer Now to launch an awareness campaign fronted by international football players Millie Bright, Jen Beattie and Bethany England urging women to check for signs of breast cancer and recurrence if they’ve been diagnosed with early breast cancer before.

The Check Her Out campaign aims to encouraging women to pause, reconnect with their bodies, and prioritise their breast health. Learn more at checkherout.co.uk

About Check Her Out
Check Her Out was developed and funded by Novartis Pharmaceuticals UK in partnership with Breast Cancer Now. The campaign encourages women to put their breast health first — checking regularly, knowing what’s normal for them, and speaking up when something changes. Checking your breasts takes only a few minutes, but it can help you spot something new or unusual sooner. 

That’s true after treatment too. For women diagnosed and treated for early breast cancer, the risk of recurrence can persist for decades, yet many feel they lack the information and support they need. While 81% report a fear of recurrence7, the majority of early breast cancer patients do not consider themselves very knowledgeable about their risk8, and most want more guidance and more open conversations with their breast care team about recurrence7. While many women understandably want to move on once treatment ends, staying informed and having open conversations about recurrence risk, monitoring and follow-up care can play an important role in long-term health and wellbeing. 

About Breast Cancer Now
We’re the UK’s leading breast cancer charity. And we’re combining the power of science and support to change breast cancer. Now. 

We’re funding world-class science now, so no one dies of breast cancer in the future. We’re here with life-changing support now, so no one faces breast cancer alone. And we’re campaigning now – for better awareness, quicker, earlier diagnosis and access to treatments – so everyone with breast can live and live well. 

We’ve been making change happen for over 50 years, and we’re not stopping now. Because we have a bold vision. That by 2050, everyone with breast cancer will live and live well. We can’t do it on our own. But together, we can make change happen. Now. 

If you’re worried about breast cancer, or have a question about breast health, we’re here. Speak to our expert nurses now by calling our free, confidential helpline on 0808 800 6000 or visit https://forum.breastcancernow.org/ 

About Novartis
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. 

In the UK, we champion health and lives through pioneering NHS partnerships, innovative collaborations and a clear focus on the greatest healthcare challenges we all face. We are where science meets hope.

To reimagine medicine with us, visit our website at https://www.novartis.com/uk-en/ and connect on LinkedIn, Facebook, and Instagram.

References

  1. January 2022 to April 2026 survey carried out online via YouGov. The figures have been weighted and are representative of all UK adults (aged 18+). 
  2. Routes to diagnosis. National Disease Registration Service.(One third of breast cancers in England are detected through breast screening).
  3. Cancer Research UK. Cancer statistics data hub. crukcancerintelligence.shinyapps.io/CancerStatsDataHub/
  4. East and North Hertfordshire Teaching NHS Trust (2025, October).The importance of early detection in Breast Cancer – East and North Hertfordshire NHS Trust
  5. Cancer registration statistics: NHS Digital (2024). Cancer registration statistics, England: 2022. Average figures for 2020-22. Public Health Scotland (2024). Cancer incidence in Scotland. Average figures for 2020-22. Welsh Cancer Intelligence and Surveillance Unit (2024). Breast cancer incidence. Average figures for 2019-21. Northern Ireland Cancer Registry (2024). Average figures for 2020-22.
  6. September 2021 survey carried out online via YouGov. The figures have been weighted and are representative of all GB adults (aged 18+). 
  7. Novartis Pharmaceuticals UK. Conducted by YouGov, (October, 2023), an online survey conducted among 1,004 UK adults aged 28 and above diagnosed with breast cancer
  8. Novartis data on file. Conducted by Novartis (November, 2023), a market research with 219 UK adults aged 18+ who had been diagnosed with early breast cancer by a healthcare professional

*Regularly checking defined as checking at least once a week, once a month, or at least once every six weeks

UK | FA-11751965 | August 2026